ClassID:

96419

C07H19/044 - CPC Classification

Classification description:

Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom Pyrrole radicals

Recent Application in this class:
#1
20250339541
2025-11-06

ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS

#2
20250213699
2025-07-03

ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS

#3
20250059226
2025-02-20

Sulfinate glycosyl donor, method for preparing same, and use thereof

#4
20240424108
2024-12-26

ASGPR-binding compounds for the degradation of extracellular proteins

#5
20240307546
2024-09-19

ASGPR-binding compounds for the degradation of extracellular proteins

#6
20240245785
2024-07-25

ASGPR-binding compounds for the degradation of extracellular proteins

#7
20240072809
2024-02-29

ASGPR-binding compounds for the degradation of extracellular proteins

#8
20230097256
2023-03-30

ASGPR-binding compounds for the degradation of extracellular proteins

#9
20200095271
2020-03-26

Indoleacetic acid derivative and preparation method and pharmaceutical use thereof

#10
20190330201
2019-10-31

Aryl hydrocarbon receptor modulators

#11
20180282363
2018-10-04

GLUCOPYRANOSIDE COMPOUND

#12
20170247403
2017-08-31

Tetracyclic anthraquinone derivatives

#13
20170081428
2017-03-23

Immunomodulating beta-1,6-D-glucans

#14
20160326207
2016-11-10

Method of suppressing formation of photocrosslink, and photoreactive nucleic acid in which auto-crosslink formation is suppressed

#15
20160108078
2016-04-21

GLUCOPYRANOSIDE COMPOUND

#16
20160095844
2016-04-07

Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives

#17
20160045531
2016-02-18

COMBINATION THERAPY FOR TREATING CANCER

#18
20150166595
2015-06-18

Tetracyclic anthraquinone derivatives

#19
20150126469
2015-05-07

Urea compounds

#20
20150111846
2015-04-23

Urea compounds

#21
20150018292
2015-01-15

Bioactive alkaloid compositions and their medical uses

#22
20140329236
2014-11-06

Non-natural nucleosides as theranostic agents

#23
20140234251
2014-08-21

Purine nucleoside analogues for treating flaviviridae including hepatitis C

#24
20140206859
2014-07-24

PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT-2

#25
20140206858
2014-07-24

Process for the preparation of compounds useful as inhibitors of SGLT-2

#26
20140155586
2014-06-05

Compound amycolamicin, method for producing the same, and use of the same

#27
20130131001
2013-05-23

Epirubicin derivatives

#28
20130122506
2013-05-16

Nucleic acid base analogs with quenching and fluorescent activities and applications thereof

#29
20120258913
2012-10-11

Glucopyranoside compound

#30
20110245484
2011-10-06

Stereoselective synthesis of phosphorus containing actives

#31
20110224161
2011-09-15

Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof

#32
20100286386
2010-11-11

Combinatorial production of nucleotide and nucleoside (XiTP) analogues

#33
20100129317
2010-05-27

AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VIRAL POLYMERASES

#34
20090258921
2009-10-15

Indole derivatives

#35
20090169507
2009-07-02

Purine nucleoside analogues for treating including hepatitis C

#36
20080293666
2008-11-27

Antibacterial agents

#37
20070060744
2007-03-15

Process for the synthesis of pyrazolopyrimidines

#38
20070032448
2007-02-08

Sugar modified nucleosides as viral replication inhibitors

#39
20060014943
2006-01-19

Process for the synthesis of pyrazolopyrimidines

#40
20060003951
2006-01-05

Anti-viral 7-deaza L-nucleosides

#41
20050075309
2005-04-07

Purine nucleoside analogues for treating Flaviviridae including hepatitis C